Shree Ganesh Biotech India Ltd
NSE: BSE: 539470
₹0.59
(9.26%)
Thu, 02 Apr 2026, 00:43 pm
Market Cap215.26M
PE Ratio0
Dividend0
Process Industries
Agricultural Commodities/Milling
24.5KShree Ganesh Biotech India Analysis
dividend
- Unable to evaluate Shree Ganesh Bio-Tech (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Shree Ganesh Bio-Tech (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Shree Ganesh Bio-Tech (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Shree Ganesh Bio-Tech (India) is profitable, therefore cash runway is not a concern.
- Shree Ganesh Bio-Tech (India) is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 110.3x debt.
- Shree Ganesh Bio-Tech (India)'s cash and other short term assets cover its long term commitments.
- Shree Ganesh Bio-Tech (India)'s level of debt (0.3%) compared to net worth is satisfactory (less than 40%).
- Low level of unsold assets.
- Operating cash flow is negative therefore debt is not well covered.
management
- The average tenure for the Shree Ganesh Bio-Tech (India) board of directors is less than 3 years, this suggests a new board.
misc
- Shree Ganesh Bio-Tech (India) is not covered by any analysts.
- BSE:539470 has not traded for 29 days.
past
- Shree Ganesh Bio-Tech (India)'s 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Shree Ganesh Bio-Tech (India)'s year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Shree Ganesh Bio-Tech (India) used its assets less efficiently than the IN Food industry average last year based on Return on Assets.
- Shree Ganesh Bio-Tech (India)'s use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Shree Ganesh Bio-Tech (India) has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Shree Ganesh Bio-Tech (India)'s 1-year earnings growth is negative, it can't be compared to the IN Food industry average.
value
- Shree Ganesh Bio-Tech (India) is overvalued based on assets compared to the IN Food industry average.
- Shree Ganesh Bio-Tech (India) is overvalued based on earnings compared to the IN Food industry average.
- Shree Ganesh Bio-Tech (India) is overvalued based on earnings compared to the India market.
- BSE:539470 is flat (0%) underperforming the Food industry which returned 5% over the past month.
- BSE:539470 is flat (0%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800